Dr Linda Rieswijk, Ph.D. (L.)
Phillips, R. V., Rieswijk, L., Hubbard, A. E., Vermeulen, R., Zhang, J., Hu, W., Li, L., Bassig, B. A., Wong, J. Y. Y., Reiss, B., Huang, Y., Wen, C., Purdue, M., Tang, X., Zhang, L., Smith, M. T., Rothman, N., & Lan, Q. (2019). Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and cancer. Epigenetics, 14(11), 1112-1124. https://doi.org/10.1080/15592294.2019.1633866
More information about this publication
Luderer, U., Eskenazi, B., Hauser, R., Korach, K. S., McHale, C. M., Moran, F., Rieswijk, L., Solomon, G., Udagawa, O., Zhang, L., Zlatnik, M., Zeise, L., & Smith, M. T. (2019). Proposed Key Characteristics of Female Reproductive Toxicants as an Approach for Organizing and Evaluating Mechanistic Data in Hazard Assessment. Environmental Health Perspectives, 127(7), Article 075001. https://doi.org/10.1289/EHP4971
More information about this publication
AstraZeneca-Sanger Drug Combination DREAM Consortium (2019). Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen. Nature Communications, 10, Article 2674. https://doi.org/10.1038/s41467-019-09799-2
More information about this publication
Guyton, K. Z., Rieswijk, L., Wang, A., Chiu, W. A., & Smith, M. T. (2018). Key Characteristics Approach to Carcinogenic Hazard Identification. Chemical Research in Toxicology, 31(12), 1290-1292. https://doi.org/10.1021/acs.chemrestox.8b00321
More information about this publication
Nymark, P., Rieswijk, L., Ehrhart, F., Jeliazkova, N., Tsiliki, G., Sarimveis, H., Evelo, C. T., Hongisto, V., Kohonen, P., Willighagen, E., & Grafstrom, R. C. (2018). A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions. Toxicological Sciences, 162(1), 264-275. https://doi.org/10.1093/toxsci/kfx252
More information about this publication
Moodley, K., Rieswijk, L., Oprea, T. I., & Dumontier, M. (2017). Assessing the quality of manually curated drug indication and usage information via ontology term mappings. Paper presented at Bio-Ontologies, Prague, Czech Republic.
More information about this publication
Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Jennen, D. G. J., van Breda, S. G. J., & Kleinjans, J. C. S. (2016). Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity. Mutagenesis, 31(5), 603-615. https://doi.org/10.1093/mutage/gew027
More information about this publication
Rieswijk, L., Claessen, S. M. H., Bekers, O., van Herwijnen, M., Theunissen, D. H. J., Jennen, D. G. J., de Kok, T., Kleinjans, J. C. S., & van Breda, S. G. J. (2016). Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma. Toxicology, 350, 31-39. https://doi.org/10.1016/j.tox.2016.05.002
More information about this publication
Rieswijk, L. (2016). MicroRNAs and epigenetics in chemical carcinogenesis : an integrative toxicogenomics-based approach. [Doctoral Thesis, Maastricht University]. Uitgeverij BOXPress. https://doi.org/10.26481/dis.20160120lr
More information about this publication
Rieswijk, L., Brauers, K. J. J., Coonen, M. L. J., Van Breda, S. G. J., Jennen, D. G. J., & Kleinjans, J. C. S. (2015). Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes. Mutagenesis, 30(6), 771-784. https://doi.org/10.1093/mutage/gev036
More information about this publication
For publications see my ORCID profile http://orcid.org/0000-0002-6106-1347
Dr Linda Rieswijk, Ph.D. (L.)
Teacher
Department of Advanced Computing Sciences/FSE Central/University Library